We asked an expert at an innovative medical imaging start-up about how they had overcome this challenge. Click now and listen to what they said.
New innovations have continued to advance surgery – especially within the spinal space. I wanted to highlight the revolutionary technology that is driving this change and shaping the future of the space.
Recently, I hosted my first CM Conversations episode on LinkedIn Live. For it, I was joined by an industry expert, Todd Usen, who is the CEO at Activ Surgical. We discussed all things AI and minimally invasive surgery.
.jpg)
If I was to tell you that senior housing providers have used AI to improve COVID-19 testing efficiencies, found answers in our sewage and even borrowed tactics from the NBA and NHL - would you believe me?
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about the increasing value of data within the space.
.jpg)
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about the company culture at Biotronik.
.jpg)
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about Biotronik's developments during the COVID-19 pandemic.
In this episode of CM Conversations, I'm joined by Wardah Inam, the CEO of Overjet, to discuss the advantages, challenges and future of AI in the dental space.
This CM Conversations episode is all about cardiac digital health and data. To take on the topic, I was joined by Ken Nelson who's the Head of Digital Health, Diagnostics, & Monitoring at Biotronik.
.jpg)
Diagnosis of heart failure must be rapid and accurate. However, that can be a challenge for doctors without the right information and data.
For this episode of CM Conversations, Ben Thompson & Jerome Richards, Directors at CM Medical, spoke with Rob Jenkins and Will Flack from F&J Agile Solutions.
In this episode of CM Conversations, our ophthalmic specialist James Pickering spoke to Fabrizio Chines, CEO of SIFI. SIFI specialise in the manufacture of pharmaceutical products for the eye care industry.
.jpg)
I spoke with CEO and serial entrepreneur Janne Huhtala who has a track record of working with start-ups in neuromodulation. This technology has the potential to change millions of people's lives.
.jpg)
We caught up with GlobeChek’s CEO William Mallon to understand the effect that the pandemic has had on his start-up and the entire ophthalmic industry.
In this episode it was all about imaging, as we caught up with Renaud Maloberti, Chief Commercial Officer for ENDRA Life Sciences.
Imaging specialist Emil Larsson has highlighted a selection of his companies to watch from ECR 2020.
A recent report from Frost & Sullivan anticipates the post Covd-19 telehealth market forecast of 64% growth versus the anticipated 32% pre-COVID-19 with a 100% growth in adoption. This is an astronomical rate of growth.
Before he founded global diabetes management platform One Drop, Founder, CEO and diabetes patient Jeff Dachis was tired of feeling like a patient, and wanted to feel more like a ‘diabadass’.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting.
As businesses prioritise the wellbeing of their employees, the concept of working a 4 day week is shifting from distant pipedream to reality for a range of organisations around the world.
In July 2018 I wrote about the part that point of care ultrasound (POCUS) would play in the future of the imaging market. I’m not sure where two years have gone, but since then the companies, personnel and their technology have evolved considerably.
Fresh approaches to AI, mixed reality, surgical robotics and CCM are changing the way we think about cardiology.
.jpg)
The demand for wound care is at an all-time high, sparking innovation from all corners of the industry.
Global ambitions, a large market-size and truly disruptive technology, are all great indicators of a company that's about to make it big in medical imaging. But which companies have these top traits?
There’s no perfect formula to becoming a successful billion-dollar company in medical imaging, or else we’d all be billionaires. However, this combination of ingredients does seem to create a common recipe for success.
Now more than ever, medical imaging is dependent on an underlying digital infrastructure. While there's a clear medical benefit, cyber security is an rising concern throughout the industry.
I’m championing three emerging companies whose technology has led their ambition, rather than R&D budgets, mergers and acquisitions.
The College of Optometrists called AI “the new buzzword in ophthalmology” and over the last 12 months it has been hitting headlines on a regular basis.
Artificial Intelligence is a new technology and, for the most part, one of its biggest challenges is just working out how it will be applied. Where it can be used best, most cost-effectively and easiest to gain the best results.
It’s difficult to measure the impact of any technology on the orthopaedics sector. That’s because the term covers such a wide range of different procedures, products and areas of the human body.
Writing for Nursing Times.net, Jacqui Fletcher referred to wound care as a ‘significant burden’ for the UK’s NHS, with the cost of treating wounds calculated at well over £5 billion per year, and rising.
Medical imaging generates around 90% of all healthcare data and is a fundamental part of healthcare. In all its forms, imaging produces phenomenal amounts of data; there are an incomprehensible number of images stored on hospital servers around the w
Everyone with access to the dentist will go at one point in their life. It’s also likely that a large proportion of that number will receive some sort of treatment.
